MTOR and central nervous system cancer: Western blot results of biomarkers associated with the AMPK/mTOR pathway in glioma stem cells are consistent with those in glioma cell lines: pathway alterations by MDHDH could be reversed by PSMA1 downregulation (Supplementary Figure S10H).